1. Home
  2. ZKH vs VALN Comparison

ZKH vs VALN Comparison

Compare ZKH & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZKH

ZKH Group Limited

HOLD

Current Price

$3.00

Market Cap

484.8M

Sector

N/A

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$5.36

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZKH
VALN
Founded
1998
2012
Country
China
France
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
484.8M
536.9M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
ZKH
VALN
Price
$3.00
$5.36
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.50
AVG Volume (30 Days)
254.9K
78.0K
Earning Date
05-19-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.02
N/A
Revenue Next Year
$10.41
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.20
$5.06
52 Week High
$3.90
$12.25

Technical Indicators

Market Signals
Indicator
ZKH
VALN
Relative Strength Index (RSI) 44.85 34.38
Support Level $2.81 $5.15
Resistance Level $3.13 $6.42
Average True Range (ATR) 0.14 0.23
MACD 0.00 0.11
Stochastic Oscillator 27.27 28.24

Price Performance

Historical Comparison
ZKH
VALN

About ZKH ZKH Group Limited

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: